Cargando…

Design and Testing of an EHR-Integrated, Busulfan Pharmacokinetic Decision Support Tool for the Point-of-Care Clinician

Background: Busulfan demonstrates a narrow therapeutic index for which clinicians routinely employ therapeutic drug monitoring (TDM). However, operationalizing TDM can be fraught with inefficiency. We developed and tested software encoding a clinical decision support tool (DST) that is embedded into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Rahman, Susan M., Breitkreutz, Matthew L., Bi, Charlie, Matzuka, Brett J., Dalal, Jignesh, Casey, K. Leigh, Garg, Uttam, Winkle, Sara, Leeder, J. Steven, Breedlove, JeanAnn, Rivera, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811899/ https://www.ncbi.nlm.nih.gov/pubmed/27065859 http://dx.doi.org/10.3389/fphar.2016.00065

Ejemplares similares

Traffic jam within lymphocytes: A clinician’s perspective
por: Hosahalli Vasanna, Smitha, et al.
Publicado: (2023)

Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
por: Seydoux, Claire, et al.
Publicado: (2023)

Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
por: Bremer, Sara, et al.
Publicado: (2015)

Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients
por: van Hoogdalem, Matthijs W., et al.
Publicado: (2020)

Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantation
por: Seydoux, Claire, et al.
Publicado: (2022)

Impact of valproic acid on busulfan pharmacokinetics: In vitro assessment of potential drug-drug interaction
por: Al-Enezi, Bashayer F., et al.
Publicado: (2023)

Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy
por: Guidolin, Valeria, et al.
Publicado: (2023)

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Bahçecioğlu, Ömer Faruk, et al.
Publicado: (2021)

Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis
por: Chan, Phyllis, et al.
Publicado: (2020)

Evaluating the Efficacy, Toxicity and Pharmacokinetic Profile of Oral Busulfan in Allogeneic Stem Cell Transplant Patients
por: Salvaris, Ross, et al.
Publicado: (2022)

“Salt in the Wound”: Safety Net Clinician Perspectives on Performance Feedback Derived From EHR Data
por: Bunce, Arwen E., et al.
Publicado: (2017)

10227 A Framework for Bringing Secondary Analysis of EHR Data to Geographically Dispersed Clinician Scientists
por: McClay, James, et al.
Publicado: (2021)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Population pharmacokinetics of oral high-dose busulfan in adult patients undergoing hematopoietic stem cell transplantation
por: Hadjibabaie, M., et al.
Publicado: (2011)

A Simple Dosing Scheme for Intravenous Busulfan Based on Retrospective Population Pharmacokinetic Analysis in Korean Patients
por: Choe, Sangmin, et al.
Publicado: (2012)

Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing
por: Neroutsos, Efthymios, et al.
Publicado: (2022)

The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study
por: Du, Xiaohuan, et al.
Publicado: (2022)

Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation
por: Dadkhah, Adrin, et al.
Publicado: (2022)

External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients
por: Huang, Huiping, et al.
Publicado: (2022)

Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance
por: Lawson, Rachael, et al.
Publicado: (2022)

Modeling EHR with the openEHR approach: an exploratory study in China
por: Min, Lingtong, et al.
Publicado: (2018)

Inpatient EHR User Experience and Hospital EHR Safety Performance
por: Classen, David C., et al.
Publicado: (2023)

EHR Conformance Testing for Enhanced Syndromic Surveillance System Interoperability
por: Snelick, Robert, et al.
Publicado: (2014)

Physician Opinions about EHR Use by EHR Experience and by Whether the Practice had optimized its EHR Use
por: Jamoom, EW, et al.
Publicado: (2016)

Fludarabine with pharmacokinetically-guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients
por: Andersson, Borje S., et al.
Publicado: (2016)

Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations
por: Yuan, Jinjie, et al.
Publicado: (2021)

Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
por: Goutelle, Sylvain, et al.
Publicado: (2022)

The complex case of EHRs: examining the factors impacting the EHR user experience
por: Tutty, Michael A, et al.
Publicado: (2019)

Mining of EHR for interface terminology concepts for annotating EHRs of COVID patients
por: Keloth, Vipina K., et al.
Publicado: (2023)

An electronic health record (EHR) log analysis shows limited clinician engagement with unsolicited genetic test results
por: Nestor, Jordan G, et al.
Publicado: (2021)

A Qualitative Analysis of the Impact of Electronic Health Records (EHR) on Healthcare Quality and Safety: Clinicians’ Lived Experiences
por: Upadhyay, Soumya, et al.
Publicado: (2022)

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
por: Saraceni, Francesco, et al.
Publicado: (2017)

Adverse Effects of Busulfan Plus Cyclophosphamide versus Busulfan Plus Fludarabine as Conditioning Regimens for Allogeneic Bone Marrow Transplantation
por: Mehdizadeh, Mahshid, et al.
Publicado: (2021)

Standard-based EHR-enabled applications for clinical research and patient safety: CDISC – IHE QRPH – EHR4CR & SALUS collaboration
por: Daniel, Christel, et al.
Publicado: (2014)

Middle East Respiratory Syndrome Coronavirus: What Do We Know?
por: Sousou, Jeanann
Publicado: (2015)

Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients
por: Ansari, M, et al.
Publicado: (2016)

Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children
por: Benadiba, Joy, et al.
Publicado: (2018)

Comparing the Certification Criteria for CCHIT-Certified Ambulatory EHR with the SNUBH's EHR Functionalities
por: Heo, Eun Young, et al.
Publicado: (2012)

Melatonin and Testicular Damage in Busulfan Treated Mice
por: Mirhoseini, Mehri, et al.
Publicado: (2014)

Systemic Histopathology of Infant Rats Exposed to Busulfan
por: Ohira, Toko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t5o8fh70m360lpbgqjb6ph90tu